Cancer Data Trends 2023July 5, 2023Breast CancerGenitourinary CancerLung CancerProstate CancerColon and RectalMelanoma
Multiprong strategy makes clinical trials less WhiteJune 23, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanomaAML
CBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Huge underuse of germline testing for cancer patientsJune 22, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncologyJune 15, 2023Mixed TopicsBreast CancerMelanomaGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
